SCHEMBL3936328

SCHEMBL3936328

CCSC[C@@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL340835 1.00
SCHEMBL685448 1.00
SCHEMBL28617956 0.89 ARG1 (0.58)
SCHEMBL36935 0.85 ARG1 (0.61)
SCHEMBL36934 0.85 ARG1 (0.61)
SCHEMBL36933 0.85 ARG1 (0.61)
SCHEMBL29393779 0.85 ARG1 (0.61)
SCHEMBL29378137 0.85 ARG1 (0.61)
SCHEMBL7211047 0.82 NOS2 (0.41)
Hydrochloric Acid SCHEMBL11112802 0.82 GSR (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4337247-A ANALGESICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1982-06-29 US claimed
US-20230391828-A1 REGULATORS OF CELL DIVISION TECHNISCHE UNIVERSITAT DRESDEN (DE) 2023-12-07 US disclosed
US-20230220033-A1 GLP-1 AGONIST POLYPEPTIDE COMPOUND AND SALT THEREOF, SYNTHESIS METHOD THEREFOR AND USE THEREOF SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. (CN) 2023-07-13 US disclosed
CN-115677482-A Synthesis method of chiral alpha-hydroxy acid 上海吉奉生物科技有限公司 2023-02-03 CN disclosed
EP-4108682-A1 GLP-1 AGONIST POLYPEPTIDE COMPOUND AND SALT THEREOF, SYNTHESIS METHOD THEREFOR AND USE THEREOF Sinopep-Allsino Biopharmaceutical Co., Ltd. (CN) 2022-12-28 EP disclosed
EP-3981784-A1 REGULATORS OF CELL DIVISION Technische Universität Dresden (DE) 2022-04-13 EP disclosed
US-20120329770-A1 CEPHALOSPORIN DERIVATIVES USEFUL AS BETA-LACTAMASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF DMITRIENKO GARY IGOR (CA) 2012-12-27 US disclosed
US-7560227-B2 Biomarkers of vulnerable atherosclerotic plaques and methods of use UNIVERSITY OF MASSACHUSETTS (US) 2009-07-14 US disclosed
US-20070207507-A1 Biomarkers of vulnerable atherosclerotic plaques and methods of use UNIVERSITY OF MASSACHUSETTS (US) 2007-09-06 US disclosed
WO-2006093973-A2 BIOMARKERS OF VULNERABLE A THEROSCLEROTIC PLAQUES AND METHODS OF USE UNIVERSITY OF MASSACHUSETTS (US) 2006-09-08 WO disclosed
US-5578470-A USING CYSTEINE NEDERLANDSE ORGANISATIE VOOR TOEGEPAST (NL) 1996-11-26 US disclosed
US-5496928-A Endothelin antagonistic substance BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-03-05 US disclosed
EP-0495963-A4 IMPROVED HYPOGLYCEMICS 1993-09-01 EP disclosed
EP-0555537-A2 Endothelin antagonistic substance BANYU PHARMACEUTICAL CO., LTD. (JP) 1993-08-18 EP disclosed
EP-0495963-A1 IMPROVED HYPOGLYCEMICS AMYLIN PHARMACEUTICALS, INC. (US) 1992-07-29 EP disclosed
WO-1992003148-A1 IMPROVED HYPOGLYCEMICS AMYLIN CORPORATION (US) 1992-03-05 WO disclosed
US-4337247-A ANALGESICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1982-06-29 US disclosed
EP-0005248-B1 TETRAPEPTIDEHYDRAZIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION Takeda Chemical Industries, Ltd. (JP) 1982-03-24 EP disclosed
EP-0031567-A2 Tetrapeptidesemicarbazide derivatives and their production and use Takeda Chemical Industries, Ltd. (JP) 1981-07-08 EP disclosed
US-4277394-A ANALGESICS, ANTIDIARRHEA, TREATMENT OF MENTAL DISEASE TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 1981-07-07 US disclosed